Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
22 Oct 2025, 18:57:28 UTC
Prior SEC filing
17 Oct 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Martin Abraham Guiloff Salvador and /s/ Luis Felipe Correa Gonzalez, Managers of South Lake One LLC

Key filing fact

South Cone Investments Limited Partnership filed Form 4 for Rani Therapeutics Holdings, Inc. (RANI) on 22 Oct 2025.

Key facts

  • This page summarizes South Cone Investments Limited Partnership's Form 4 filing for Rani Therapeutics Holdings, Inc. (RANI).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 22 Oct 2025, 18:57.

Change

  • Previous filing in this sequence was filed on 17 Oct 2024.
  • Current net transaction value: -$15,711,314.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001876412 Primary reporting owner

South Cone Investments Limited Partnership

Relationship
10%+ Owner
Address
AVENIDA PRESIDENTE RIESCO 5711,, OFICINA 1603, LAS CONDES, SANTIAGO, CHILE
Signature
/s/ Martin Abraham Guiloff Salvador and /s/ Luis Felipe Correa Gonzalez, Managers of South Lake One LLC
Signature date
22 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RANI transaction

Class A Common Stock

Sale

Transaction value
$4,637,314
Shares
-1,923,000
Change %
-23%
Price
$2.41*
Shares after
6,379,194
Date
20 Oct 2025
Ownership
Shares indirectly held through South Lake One LLC
Footnotes
F1, F2
RANI transaction

Class A Common Stock

Sale

Transaction value
$11,074,000
Shares
-4,000,000
Change %
-63%
Price
$2.77*
Shares after
2,379,194
Date
21 Oct 2025
Ownership
Shares indirectly held through South Lake One LLC
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

South Cone Investments Limited Partnership is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 3 footnotes

Footnote F1

The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.25 to $2.61, inclusive. The reporting person undertakes to provide to Rani Therapeutics Holdings, Inc. ("Rani"), any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Footnote F2

South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

Footnote F3

The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.50 to $3.09, inclusive. The reporting person undertakes to provide to Rani, any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .